Global Enzyme-linked Immunosorbent Assay (Elisa) Testing Market 2018-2022

  • ID: 4538698
  • Report
  • Region: Global
  • 111 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abcam
  • BD
  • bioMérieux
  • Bio-Rad Laboratories
  • Thermo Fisher Scientifi
  • MORE
About Enzyme-linked Immunosorbent Assay (Elisa) Testing

Enzyme-linked immunosorbent assay (ELISA) is mainly used to measure antibodies, antigens, proteins, and glycoproteins in biological samples.

The analysts forecast the global enzyme-linked immunosorbent assay (Elisa) testing market will register a revenue of more than USD 560 million by 2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global enzyme-linked immunosorbent assay (Elisa) testing market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, Global Enzyme-linked Immunosorbent Assay (Elisa) Testing Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Abcam
  • BD
  • bioMérieux
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific
Market drivers
  • Growing need for frequent testing among the aging population
  • For a full, detailed list, view the full report
Market challenges
  • Lack of accessibility and affordability of diagnostic tests in developing countries
  • For a full, detailed list, view the full report
Market trends
  • Increasing cases of cancer
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abcam
  • BD
  • bioMérieux
  • Bio-Rad Laboratories
  • Thermo Fisher Scientifi
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 05: MARKET SIZING
  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 07: CUSTOMER LANDSCAPE

PART 08: MARKET SEGMENTATION BY END-USER
  • Segmentation by end-user
  • Comparison by end-user
  • Hospitals and diagnostic centers - Market size and forecast 2017-2022
  • Research laboratories - Market size and forecast 2017-2022
  • Others - Market size and forecast 2017-2022
  • Market opportunity by end-user
PART 09: REGIONAL LANDSCAPE
  • Geographical segmentation
  • Regional comparison
  • Americas - Market size and forecast 2017-2022
  • EMEA - Market size and forecast 2017-2022
  • APAC - Market size and forecast 2017-2022
  • Market opportunity
PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 12: MARKET TRENDS
  • Growing importance of promotional activities
  • Increasing cases of cancer
  • Emergence of new disease targets
PART 13: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 14: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abcam
  • BD
  • bioMérieux
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific
PART 15: APPENDIX
  • List of abbreviations
List of Exhibits
Exhibit 01: Parent market
Exhibit 02: Global immunoassay market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global ELISA testing market 2017-2022 ($ mn)
Exhibit 09: Global - Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Customer landscape
Exhibit 19: End-user - Market share 2017-2022 (%)
Exhibit 20: Comparison by end-user
Exhibit 21: Hospitals and diagnostic centers - Market size and forecast 2017-2022 ($ mn)
Exhibit 22: Hospitals and diagnostic centers - Year-over-year growth 2018-2022 (%)
Exhibit 23: Research laboratories - Market size and forecast 2017-2022 ($ mn)
Exhibit 24: Research laboratories - Year-over-year growth 2018-2022 (%)
Exhibit 25: Others - Market size and forecast 2017-2022 ($ mn)
Exhibit 26: Others - Year-over-year growth 2018-2022 (%)
Exhibit 27: Market opportunity by end-user
Exhibit 28: Global - Market share by geography 2017-2022 (%)
Exhibit 29: Regional comparison
Exhibit 30: Americas - Market size and forecast 2017-2022 ($ mn)
Exhibit 31: Americas - Year-over-year growth 2018-2022 (%)
Exhibit 32: Top 3 countries in Americas
Exhibit 33: EMEA - Market size and forecast 2017-2022 ($ mn)
Exhibit 34: EMEA - Year-over-year growth 2018-2022 (%)
Exhibit 35: Top 3 countries in EMEA
Exhibit 36: APAC - Market size and forecast 2017-2022 ($ mn)
Exhibit 37: APAC - Year-over-year growth 2018-2022 (%)
Exhibit 38: Top 3 countries in APAC
Exhibit 39: Market opportunity
Exhibit 40: Advantages of disease diagnosis
Exhibit 41: Barriers for the diagnostics market in developing countries
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: Abcam overview
Exhibit 48: Abcam - Business segments
Exhibit 49: Abcam - Organizational developments
Exhibit 50: Abcam - Geographic focus
Exhibit 51: Abcam - Segment focus
Exhibit 52: Abcam - Key offerings
Exhibit 53: BD overview
Exhibit 54: BD - Business segments
Exhibit 55: BD - Organizational developments
Exhibit 56: BD - Geographic focus
Exhibit 57: BD - Segment focus
Exhibit 58: BD - Key offerings
Exhibit 59: bioMérieux overview
Exhibit 60: bioMérieux - Business segments
Exhibit 61: bioMérieux - Organizational developments
Exhibit 62: bioMérieux - Geographic focus
Exhibit 63: bioMérieux - Segment focus
Exhibit 64: bioMérieux - Key offerings
Exhibit 65: Bio-Rad Laboratories overview
Exhibit 66: Bio-Rad Laboratories - Business segments
Exhibit 67: Bio-Rad Laboratories - Organizational developments
Exhibit 68: Bio-Rad Laboratories - Geographic focus
Exhibit 69: Bio-Rad Laboratories - Segment focus
Exhibit 70: Bio-Rad Laboratories - Key offerings
Exhibit 71: Thermo Fisher Scientific overview
Exhibit 72: Thermo Fisher Scientific - Business segments
Exhibit 73: Thermo Fisher Scientific - Organizational developments
Exhibit 74: Thermo Fisher Scientific - Geographic focus
Exhibit 75: Thermo Fisher Scientific - Segment focus
Exhibit 76: Thermo Fisher Scientific - Key offerings
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abcam
  • BD
  • bioMérieux
  • Bio-Rad Laboratories
  • Thermo Fisher Scientifi
  • MORE
New Report Released: - Global Enzyme-linked Immunosorbent Assay (Elisa) Testing Market 2018-2022

The author of the report recognizes the following companies as the key players in the global enzyme-linked immunosorbent assay (Elisa) testing market: Abcam, BD, bioMérieux, Bio-Rad Laboratories, and Thermo Fisher Scientific.

Commenting on the report, an analyst from the research team said: “One trend in the market is increasing cases of cancer. The increasing incidences of cancer is one of the key trends that will gain traction in the enzyme-linked immunosorbent assay (ELISA) testing market during the next few years. Owing to factors such as unhealthy diet, lack of physical activity, tobacco use, and excessive consumption of alcohol, there is an increase in the prevalence of cancer.”

According to the report, one driver in the market is growing need for frequent testing among the aging population. According to the world bank, there is a considerable increase in the older population (65 years and above) and this population account for more than 8% of the global population. This population is prone to several types of communicable and non-communicable diseases such as cardiovascular disease, lung disease, and cancer, which drives the demand for the prevention, diagnosis, and treatment of such diseases.

Further, the report states that one challenge in the market is lack of accessibility and affordability of diagnostic tests in developing countries. High-quality diagnostic tests are easily available for various diseases in majority of these developed countries. However, they are neither affordable nor accessible in developing countries where disease burden is high.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Abcam
  • BD
  • bioMérieux
  • Bio-Rad Laboratories
  • Thermo Fisher Scientifi
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll